Register to chat with like-minded investors on our interactive forums.
Medical
5 Biotechs with Acquisition Rumors Associated With Them
Oct 03 2013 @ 11:54
Oftentimes insiders tend to talk and leak information, and these rumors end up hitting the street. However, there is...
AcelRx Looks Poised To Break Out Soon
Oct 02 2013 @ 11:22
I have been hearing some strong acquisition rumors concerning Acel, much like I heard about Obagi last year. The...
Upcoming FDA Approval Decision For Antares Pharma Provides Cataylst Trade Opportunity
Oct 01 2013 @ 07:51
At Stockmatusow, we’ve spent a lot of time in the past two years focusing on Antares Pharma (NASDAQ: ATRS) and...
Upcoming Catalysts For These BioTechs Should Rally Them Substantially
Sep 27 2013 @ 09:16
Today, StockMatusow highlights five companies with near-term catalysts along with positive sentiment that we feel...
Halozyme To Release Important Data This Coming Monday
Sep 26 2013 @ 10:41
StockMatusow’s best small cap Biopharma pick, Halozyme, (NASDAQ: HALO) will present its full data on PEGPH20...
Is An Acquisition Of Solta Medical Imminent?
Sep 25 2013 @ 08:41
In my last article concerning Solta Medical Devices (NASDAQ: SLTM), I remarked several times how I feel the company...
Insiders Of AcelRx Have Facilitated A Combined 13 Acquisitions: NDA To Be Filed At Month's End
Sep 19 2013 @ 06:44
We feel that AcelRx Pharmaceuticals (NASDAQ: ACRX) warrants a close look by both longer-term investors and...
End Of September Catalyst: Pancreatic Cancer Data For HaloZyme
Sep 17 2013 @ 07:04
Halozyme (NASDAQ: HALO) is developing PEGPH20 ((PEGylated recombinant human hyaluronidase) in combination with...
The Baker Brothers Increase Shares In Halozyme By 105%, Insider Makes Big Buy And Options Heat Up
Sep 04 2013 @ 10:59
Often times, certain biotech institutional investors just seem to pick winner after winner, and stay on a hot streak...
BioPharma Catalyst Trade Pick Of The Week: Biodel
Aug 21 2013 @ 11:08
Going long ahead of certain biopharma catalysts have proven to be a very successful trade this year, especially...
